AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 201 filers reported holding AXSOME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $372,163 | -53.0% | 5,179 | -59.6% | 0.03% | -35.4% |
| Q1 2023 | $791,601 | -17.9% | 12,834 | +2.6% | 0.05% | -25.0% |
| Q4 2022 | $964,588 | +54.8% | 12,506 | -10.4% | 0.06% | +56.1% |
| Q3 2022 | $623,000 | -8.7% | 13,962 | -21.6% | 0.04% | +13.9% |
| Q2 2022 | $682,000 | +0.9% | 17,809 | +9.0% | 0.04% | +2.9% |
| Q1 2022 | $676,000 | +27.8% | 16,344 | +16.7% | 0.04% | +9.4% |
| Q4 2021 | $529,000 | +65.3% | 14,009 | +44.4% | 0.03% | +77.8% |
| Q3 2021 | $320,000 | -62.9% | 9,700 | -24.1% | 0.02% | -60.9% |
| Q2 2021 | $862,000 | +42.7% | 12,772 | +19.8% | 0.05% | +35.3% |
| Q1 2021 | $604,000 | +9.6% | 10,661 | +57.7% | 0.03% | -15.0% |
| Q4 2020 | $551,000 | -74.1% | 6,760 | -77.3% | 0.04% | -42.0% |
| Q3 2020 | $2,126,000 | -7.8% | 29,842 | +6.4% | 0.07% | +15.0% |
| Q2 2020 | $2,307,000 | +33.9% | 28,035 | -4.3% | 0.06% | +33.3% |
| Q1 2020 | $1,723,000 | -92.7% | 29,289 | -87.1% | 0.04% | -86.4% |
| Q4 2019 | $23,517,000 | – | 227,526 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |